Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment

被引:0
作者
Kosuke Kobayashi
Yoshihiro Ono
Yuki Kitano
Atsushi Oba
Takafumi Sato
Hiromichi Ito
Yoshihiro Mise
Eiji Shinozaki
Yosuke Inoue
Kensei Yamaguchi
Akio Saiura
Yu Takahashi
机构
[1] Japanese Foundation for Cancer Research,Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital
[2] Juntendo University School of Medicine,Department of Hepatobiliary and Pancreatic Surgery
[3] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Department of Gastroenterological Chemotherapy
来源
Annals of Surgical Oncology | 2023年 / 30卷
关键词
Colorectal liver metastases; Liver resection; Perioperative chemotherapy; Tumor markers; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:7338 / 7347
页数:9
相关论文
共 158 条
[1]  
Adam R(2012)The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus Oncologist. 17 1225-1239
[2]  
De Gramont A(2009)Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy J Clin Oncol. 27 3677-3683
[3]  
Figueras J(2004)Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg. 4 44-57
[4]  
Guthrie A(2009)Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol. 11 1829-1835
[5]  
Kokudo N(2023)Optimizing the selection of technically unresectable colorectal liver metastases Surgery. 73 442-449
[6]  
Kunstlinger F(2019)Impact of surgical treatment for recurrence after 2-stage hepatectomy for colorectal liver metastases, on patient outcome Ann Surg. 269 322-330
[7]  
Kopetz S(2008)Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet. 371 1007-1016
[8]  
Chang GJ(2014)Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial Lancet Oncol. 15 601-611
[9]  
Overman MJ(2006)Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol. 24 2065-2072
[10]  
Eng C(2011)Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy Ann Surg Oncol. 18 421-430